Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,273 articles

Articles by Daniel Marsh

Nebius Group Slips Amid Capex Concerns Despite Nasdaq-100 Inclusion
Markets

Nebius Group Slips Amid Capex Concerns Despite Nasdaq-100 Inclusion

Nebius fell 5.66% on its third day in the Nasdaq-100, as heavy capex and a delayed Meta contract weighed on sentiment. The stock rebounded 5.14% after hours.

NBIS NDAQ META MSFT NVDA
Freshworks Shares Surge on Heavy Volume Ahead of Russell Index Rebalance
Markets

Freshworks Shares Surge on Heavy Volume Ahead of Russell Index Rebalance

Freshworks rallied 1.96% to $9.37 on volume equal to 17% of its float, just before the June 26 Russell rebalance. The stock is still down 23.5% YTD as cost cuts continue.

FRSH IWM
SpaceX Russell Inclusion Spurs $2.68B in Buying, Short Interest Rises
Markets

SpaceX Russell Inclusion Spurs $2.68B in Buying, Short Interest Rises

Russell index rebalance may drive $2.68B in SpaceX buying, while the company faces $1.46B in annual bond payments and a 31.5% drop from its post-IPO high.

JEF IBKR
Alphabet Stock Dips Despite Major Dow Inclusion and $1.75B ETF Rebalancing
Markets

Alphabet Stock Dips Despite Major Dow Inclusion and $1.75B ETF Rebalancing

Alphabet (GOOGL) closed down 0.24% on Wednesday as tech sector pressures outweighed the $1.75 billion ETF buying expected from its Dow inclusion on June 29.

GOOGL VZ DIA
Target Hits New High on Wolfe Upgrade, Retail Strategy Shift
Markets

Target Hits New High on Wolfe Upgrade, Retail Strategy Shift

Target surged 5.3% to a 52-week high after Wolfe Research upgraded the stock to Outperform, citing strong store execution and rising non-merchandise sales.

TGT WMT COST SPY
Transocean Stock Dives 4.5% as Oil Price Rout Stings Offshore Drillers
Markets

Transocean Stock Dives 4.5% as Oil Price Rout Stings Offshore Drillers

Transocean (RIG) shares fell 4.5% to $5.04 as oil prices slumped, threatening offshore drilling spending despite $185 million in new contracts and a $7.1 billion backlog. The pending $5.8 billion Valaris merger faces U.S. antitrust review.

RIG VAL NE SDRL USO
IREN shares tumble 9.5% as Bitcoin slide and AI spending jitters weigh
Markets

IREN shares tumble 9.5% as Bitcoin slide and AI spending jitters weigh

IREN shares fell 9.5% to $49.51, underperforming peers, as Bitcoin slid below $60,000 and analysts questioned its AI cloud pivot, chip delivery risks, and $4.4 billion revenue goal.

IREN MSFT NVDA DELL
Costco Set to Open First Pensacola Warehouse on June 25
Markets

Costco Set to Open First Pensacola Warehouse on June 25

Costco opens its first Pensacola warehouse on June 25, entering a market with Sam's Club and BJ's. The company reported 11.6% Q3 sales growth and aims for 30+ new openings per year.

COST WMT BJ
Dow Edges Up as Tech Drags S&P 500 and Nasdaq Lower
Markets

Dow Edges Up as Tech Drags S&P 500 and Nasdaq Lower

The Dow Jones Industrial Average gained 0.34% as tech stocks declined, dragging the S&P 500 and Nasdaq lower. Attention turns to Micron's earnings after the bell, with AI spending and inflation data in focus.

MU XOM CVX FXI GLD USO XLK XLE SSNLF
Dow Rises on Oil Drop; Tech Weakness Weighs on Nasdaq
Markets

Dow Rises on Oil Drop; Tech Weakness Weighs on Nasdaq

The Dow Jones rose 0.36% as falling oil prices lifted airline stocks, while the Nasdaq fell 0.43% on continued tech weakness. Markets await Micron earnings and PCE data.

DIA SPY QQQ NVDA INTC MRVL AMD MU GOOGL GOOG AAPL AMZN MSFT VZ USO
Absci Surges on Positive Phase 1 Data for Hair Loss Drug and $100M Capital Raise
Markets

Absci Surges on Positive Phase 1 Data for Hair Loss Drug and $100M Capital Raise

Absci shares soared 35% to $10.01 after early Phase 1 safety data for its hair-loss antibody ABS-201 showed no serious adverse events, and the company raised $100 million in a stock offering.

ABSI LLY
AT&T Faces Regulatory Hurdles, Fiber Expansion Costs Weigh on Shares
Markets

AT&T Faces Regulatory Hurdles, Fiber Expansion Costs Weigh on Shares

AT&T shares dropped 0.34 to 22.48 after forecasting Q2 free cash flow below estimates due to fiber expansion costs and regulatory pushback in California.

T TMUS VZ